ArticleOncotarget2017

Risk assessment models to evaluate the necessity of prostate biopsies in North Chinese patients with 4-50 ng/mL PSA.

Jing Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.